ARC Discovery - $325,000

Tuberculosis (TB) is a lung disease of worldwide prevalence. Treatment times are long and mortality is high in children and the elderly. Current treatments are ineffective and drug resistant TB is a real pandemic threat. We will develop a cost-effective nano-particle system that can be incorporated into conventional nebulisers for use worldwide.